Our Science

Publications by program:

ETX2514: A broad-spectrum and potent inhibitor of class A, C, and D beta-lactamases.

ETX0282: An orally available, broad-spectrum inhibitor of calss A and C beta-lactamases.

Zoliflodacin (ETX0914):

Publications by year:

Publications 2018

Publications 2017

Publications 2016

Publications 2015

Publications 2014

Publications 2013

Publications 2012



“Our scientific approach and expertise, coupled with Entasis’ strong pipeline of programs, really make us stand out in the field of antibacterial drug discovery and development.”

— Satenig Guler, Senior Scientist